• Lead the development of global labelling content strategies for assigned products, ensuring alignment with the Target Product Profile and broader asset strategy.

• Develop and maintain core labelling documents and major market labels (e.g. CDS, USPI, EU SmPC/PIL).

• Contribute to defining key product claims, ensuring clarity, scientific integrity, and compliance.

• Collaborate with cross-functional teams (Regulatory, Clinical, Safety, Medical, Commercial) to enable alignment on labelling strategy and content.

• Contribute to, and where appropriate lead, interactions with Health Authorities, supporting evidence-based and compliant outcomes.

• Monitor competitor intelligence, regulatory trends, and evolving guidance to inform labelling strategy.

• Support the development of robust evidence packages and associated regulatory documentation.

• Represent global labelling in governance forums and contribute to decision-making discussions.

• Support knowledge sharing, mentoring, and continuous improvement within the labelling community.

Essential Requirements

• Fluency in English (written and spoken).

• Demonstrated capability in Global Labelling and/or Global Regulatory Affairs, with a strong focus on labelling across development and lifecycle stages.

• Ability to lead labelling strategy for complex assets, shaping key claims and supporting alignment across governance forums.

• Strong understanding of drug development, benefit–risk, and safety, with the ability to translate clinical data into clear, compliant labelling content.

• Working knowledge of global labelling standards and major Health Authority expectations, including development and maintenance of core and major market labelling.

• Ability to lead and influence cross-functional teams within a global matrix environment.

Commitment to Diversity and Inclusion / EEO paragraph

Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.